Press Release

Mitral Valve Disease Market to Grow with a CAGR of 8.90% through 2028

Increase in the incidence of Cardiovascular Disease deficiencies and increase in technological advancements is expected to drive the Global Mitral Valve Disease Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Mitral Valve Disease Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Mitral Valve Disease Market stood at USD 2.75 billion in 2022 and is anticipated to grow with a CAGR of 8.90% in the forecast period, 2024-2028. The awareness among individuals regarding Mitral Valve Disease has led to favorable market conditions for the global Mitral Valve Disease market. Several factors contribute to the growth of various Mitral Valve Disease products.

The Global Mitral Valve Disease Market faces substantial challenges due to stringent regulatory requirements and compliance standards enforced by health authorities. Maneuvering through these regulations, securing essential approvals, and guaranteeing adherence can present notable hurdles for both manufacturers and healthcare establishments. The introduction of novel mitral valve disease treatment solutions frequently entails the necessity of conducting extensive clinical trials to establish their safety and effectiveness. Fulfilling these demanding trial criteria can be a resource-intensive and time-consuming endeavor.

In rural or remote areas, there is often a deficiency in specialized medical facilities and skilled healthcare professionals necessary for the diagnosis and treatment of mitral valve diseases. As a consequence, individuals residing in these regions may encounter prolonged travel durations to access suitable healthcare centers. Financial obstacles arise from substantial out-of-pocket costs, exacerbated by insufficient insurance coverage, which obstructs their ability to obtain high-quality care. This predicament is especially challenging for individuals with limited financial means, which will further fuel market growth.

In September 2023, Abbott completes acquisition of Bigfoot Biomedical, a privately held company that develops and commercializes automated insulin delivery systems. The acquisition is expected to accelerate Abbott's efforts to develop personalized, connected solutions for people with diabetes.

The availability of favorable reimbursement policies for mitral valve disease treatments has incentivized both healthcare providers and patients to pursue necessary interventions. Insurance coverage and government programs that support these treatments have made them more accessible and affordable to a broader spectrum of the population.

In today's fast-paced world, MVD can lead to symptoms like fatigue and shortness of breath, making it challenging for individuals to keep up with the demands of a fast-paced lifestyle. Activities that once seemed effortless may become strenuous, limiting physical endurance. For individuals in the workforce, MVD symptoms can reduce productivity. Fatigue, palpitations, and dizziness can disrupt concentration and focus, making it difficult to meet professional obligations. The symptoms of MVD, including limitations on physical activity, can affect one's social life. Individuals may find it harder to engage in social events, travel, or participate in recreational activities, which are integral to maintaining a balanced and fulfilling lifestyle. Dealing with a chronic condition like MVD can lead to psychological stress. Coping with symptoms, medical appointments, and potential surgical interventions can be emotionally challenging and contribute to stress and anxiety. The costs associated with the diagnosis, treatment, and management of MVD, including medical bills, medications, and potential surgical procedures, can impose a financial burden. Managing these expenses in a fast-paced world where financial stability is vital can be daunting. MVD can significantly impact one's overall quality of life. The combination of physical limitations reduced social activities, and potential psychological distress can erode the sense of well-being and fulfillment. In a fast-paced world, being prepared for unexpected events is essential. MVD can complicate responses to emergencies, as symptoms like chest pain or palpitations may mimic cardiac emergencies, leading to uncertainty and the need for immediate medical attention.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Mitral Valve Disease Market.”

 

Educational campaigns, medical conferences, and advocacy groups have all played a part in disseminating knowledge about the importance of timely diagnosis and treatment. Patients are now more likely to seek medical attention when they experience symptoms like shortness of breath, chest pain, or irregular heartbeats, which are indicative of mitral valve issues.

In recent times, Individuals with MVD may need to adapt their lifestyle, including dietary habits, exercise routines, and work-life balance, to accommodate their condition. These adjustments can be necessary but may require effort and planning. Given the demands of a fast-paced world, the timely diagnosis and effective management of MVD are crucial. Early intervention can help alleviate symptoms, improve quality of life, and reduce the impact of the condition on daily activities. However, the Expensive Surgical Procedures may hinder market growth. Moreover, challenges related to Limited Access to Advanced Healthcare Services may pose obstacles to the Mitral Valve Disease market in the near future.

The Global Mitral Valve Disease Market is segmented into treatment, indication, end-user, regional distribution, and company.

Based on its treatment, the Mitral valve repair is favored for its ability to preserve the patient's native valve tissue, known as the "valvuloplasty" approach. Unlike mitral valve replacement, where the damaged valve is entirely replaced with a prosthetic one, repair techniques aim to restore and reconstruct the patient's natural valve. Repair maintains the functionality of the patient's own valve, allowing it to continue regulating blood flow effectively. This is crucial for long-term cardiac health. Since the native tissue is retained, there is a reduced risk of complications associated with prosthetic valves, such as blood clots, infections, and valve-related degeneration. Patients who undergo successful mitral valve repair typically experience better postoperative outcomes, including fewer symptoms, improved exercise capacity, and a higher quality of life.

Based on region, North America segment is expected to grow during the forecast period.  North America boasts a well-developed healthcare infrastructure with access to cutting-edge technologies, specialized cardiac care centers, and a skilled healthcare workforce. The region has a high prevalence of cardiovascular diseases, including mitral valve diseases, primarily due to factors like an aging population, lifestyle-related risk factors, and advanced diagnostic capabilities. North America leads in technological advancements, including minimally invasive procedures, which are preferred for mitral valve disease treatment. The region invests significantly in research and development, contributing to the development of innovative treatment modalities and medical device.

The Asia-Pacific market is poised to be the fastest-growing market, offering lucrative growth opportunities for Mitral Valve Disease players during the forecast period. Factors such as Asia-Pacific continue to grow, there is an increased capacity for healthcare spending, leading to improved access to advanced cardiac care and treatment options. The region is experiencing a demographic shift with an aging population, which is expected to drive an increase in mitral valve disease cases. Growing awareness about heart health and the availability of advanced treatments is encouraging patients to seek timely medical intervention. Some countries in Asia-Pacific, such as India and Thailand, have become popular destinations for medical tourism, attracting patients from around the world seeking cost-effective yet high-quality healthcare, including mitral valve disease treatment. Governments in several Asian countries are investing in healthcare infrastructure development, research, and training programs to enhance cardiac care capabilities. The region is witnessing the expansion of healthcare facilities, including cardiac centers and specialized hospitals, catering to the growing demand for cardiovascular treatments.

 

Major companies operating in Global Mitral Valve Disease Market are:

  • Corcym UK Limited
  • Abbott Laboratories Inc
  • Zydus Lifesciences Limited
  • Medtronic plc
  • Edwards Lifesciences Corporation
  • Affluent Medical SA
  • ShockWave Medical, Inc.
  • Valcare Medical
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The advancement in technology and increasing consumer awareness are key drivers of the Mitral Valve Disease market. In recent years, the Growing awareness campaigns, medical education initiatives, and advocacy groups have raised awareness about the importance of early diagnosis and treatment of mitral valve diseases. Patients and healthcare providers are increasingly proactive in seeking and delivering care. Rising consumer acceptance and continuous product innovation will further ensure the growth of the Mitral Valve Disease and supplements market in the coming years.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Mitral Valve Disease Market – Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 Segmented By Treatment Type (Repair, Replacement, Cardiac Resynchronization Therapy, Therapeutics), By Indication (Stenosis, Prolapse, Regurgitation), By End-User (Hospitals, Ambulatory Surgical Centers, Others), By Region, Competition”, has evaluated the future growth potential of Global Mitral Valve Disease Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Mitral Valve Disease Market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com


Relevant News